Ad-REIC Gene Therapy: Promising Results in a Patient with Metastatic CRPC following Chemotherapy

Ad-REIC Gene Therapy: Promising Results in a Patient with Metastatic CRPC following Chemotherapy

Show other versions (1)

A 63-year-old man with metastatic castration-resistant prostate cancer (CRPC) was successfully treated for two years with in situ gene therapy using an adenovirus vector carrying the human REIC/Dkk-3 gene (Ad-REIC), following chemotherapy. Ad-REIC mediates simultaneous induction of cancer-selective...

Full description

Bibliographic Details
Main Authors: Hiromi Kumon, Katsumi Sasaki, Yuichi Ariyoshi, Takuya Sadahira, Shin Ebara, Takao Hiraki, Susumu Kanazawa, Hiroyuki Yanai, Masami Watanabe, Yasutomo Nasu
Format: Article
Language:English
Published: SAGE Publishing 2015-01-01
Series:Clinical Medicine Insights: Oncology
Online Access:https://doi.org/10.4137/CMO.S23252

Internet

https://doi.org/10.4137/CMO.S23252

Similar Items